|
Crosslink Genetics Corporation is an emerging biotechnology company founded to capitalize
on recent advances in understanding of molecular mechanisms of gene regulation. Our mission is to develop a novel class of
drugs that regulate gene expression to improve the treatment of many chronic and fatal diseases caused by gene malfunction
such as cancer, immune disorders and metabolic diseases. These new drugs - called Artificial Transcription Factors (ATFs)
- are synthetic functional mimics of eukaryotic transcription factor proteins, and represent a breakthrough in artificial
gene regulation.
|
